1. Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, et al. SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv. 2018;92:124–40.
2. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, ESC Scientific Document Group, et al. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;2018(39):763–816.
3. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2017;135:e726–79.
4. Torii S, Kolodgie FD, Virmani R, Finn AV. IN..PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives. Med Devices (Auckl). 2019;12:53–64.
5. Ibrahim T, Dirschinger R, Hein R, Jaitner J. Downstream panniculitis secondary to drug-eluting balloon angioplasty. JACC Cardiovasc Interv. 2016;9:e177–9.